GlassScriptPhysician profile
Dylan Michael Carlisle
NPI 1518426295
$2,015.22
in general payments reported to CMS, 2019-2025
18 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $140 · 2021: $481 · 2022: $437 · 2023: $247 · 2024: $116 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $602.92 | 2021-2025 | Nuzyra |
| Stryker Corporation | $528.20 | 2019-2025 | Ortholoc 2 Lapifuse, Ortholoc 3di |
| Horizon Therapeutics Plc | $169.70 | 2019-2022 | |
| Treace Medical Concepts, INC. | $168.54 | 2022-2025 | |
| Medtronic, INC. | $72.64 | 2022 | |
| Organogenesis INC. | $71.67 | 2021-2022 | |
| Paragon 28, INC. | $55.66 | 2019-2022 | |
| Globus Medical, INC. | $48.18 | 2025 | Senza |
| Peerless Surgical INC. | $47.78 | 2025 | |
| Sebela Pharmaceuticals INC. | $47.34 | 2019-2022 | |
| Bioventus LLC | $45.96 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Ani Pharmaceuticals, INC. | $33.61 | 2024 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $26.95 | 2024 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $26.32 | 2021 | |
| Wright Medical Technology, INC. | $21.22 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.02 | 2025 | Krystexxa |
| Smith+Nephew, INC. | $14.36 | 2019 | |
| Advanced Oxygen Therapy INC. | $13.15 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Carlisle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.